MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Patient experiences in essential tremor: mapping functional impacts to existing measures using qualitative research

    M. Gerbasi, D. Goss, J. Petrillo, M. Nejati, S. Lewis (Cambridge, USA)

    Objective: To understand patient experience in essential tremor (ET), describe meaningful concepts related to treatment benefit, and compare concepts to existing clinical outcome assessments (COAs).…
  • 2023 International Congress

    Connectivity Profile for Deep Brain Stimulation in Early-Stage Parkinson’s Disease

    M. Hacker, N. Rajamani, C. Neudorfer, B. Hollunder, S. Oxenford, N. Li, A. Sternberg, T. Davis, P. Konrad, A. Horn, D. Charles (Nashville, USA)

    Objective: To describe the relationship between stimulation location and motor progression for the deep brain stimulation (DBS) in early-stage Parkinson’s disease (PD) pilot trial cohort…
  • 2023 International Congress

    Coping strategies in people with Parkinson disease (PwP)

    M A. Bacigalupe, D. Merino (La Plata, Argentina)

    Objective: To compare how PwP coped in two situations along their lives: (a) Parkinson disease diagnosis and (b) COVID-19 pandemic, and how their environment played…
  • 2023 International Congress

    Breast carcinoma presenting with anti-amphiphysin antibody-associated stiff-limb syndrome

    AM. Dy Closas, AH. Tan, KJ. Goh, JP. Schee, MH. See, SML. Tai, SY. Lim (Kuala Lumpur, Philippines)

    Objective: {case report) Background: {case report) Method: {case report) Results: Stiff-limb syndrome (SLS) is an uncommon variant within the stiff-person spectrum of disorders (SPSD) and…
  • 2023 International Congress

    Flavonoid intake and risk of Parkinson’s Disease

    H. Sandoval Insausti, K. Bjornevik, J. Chavarro, M. Cortese, M. Flores, A. Hung, M. Schwarzschild, T. Yeh, A. Ascherio (Boston, USA)

    Objective: To prospectively examine the association between the intake of flavonoids and their subclasses (flavanones, anthocyanins, flavan-3-ols, flavonols, flavones, and polymers) and the risk of…
  • 2023 International Congress

    The feasibility and efficacy of speech therapy via video call in patients with Parkinson’s disease: a preliminary study

    HJ. Chang, J. Kim, KA. Woo, JY. Joo, S. Kim, S. Lee, B. Jin, HY. Jeon, B. Jeon, HJ. Kim (Daejeon, Republic of Korea)

    Objective: To evaluate the feasibility and efficacy of video call-based speech therapy for patients with Parkinson’s disease (PD) with speech problems. Background: PD patients commonly…
  • 2023 International Congress

    A comparative study of non-motor symptoms in Huntington’s disease and Parkinson’s disease

    WZ. Hu, JH. Yin, LX. Cao, Y. Huang (Beijing, China)

    Objective: To assess and compare the non-motor symptoms (NMS) profile in Parkinson's disease (PD) and Huntington's disease (HD) patients using Parkinson's Disease Non-Motor Symptom Rating…
  • 2023 International Congress

    Stiff-person syndrome associated with anti-Yo1 antibodies: a case report

    E. Chekanova, I. Luneva, A. Kozlova, O. Smetanina, M. Zakharova (Moscow, Russian Federation)

    Objective: To present an unusual presentation of paraneoplastic stiff-person syndrome (SPS). Background: SPS may have paraneoplastic, autoimmune, or cryptogenic etiology and most often be associated…
  • 2023 International Congress

    Cardiovascular complications in Parkinsonism: insights from Luxembourg Parkinson’s Study

    S. Acharya, A. Lumley, Y. Devaux (Strassen, Luxembourg)

    Objective: Our study aimed at determining the frequency and risk of cardiovascular diseases (CVDs) in Parkinsonian patients in the Luxembourg Parkinson’s Study (LuxPARK). Background: The…
  • 2023 International Congress

    Long duration response to levodopa in advanced Parkinson disease

    P. Nieto, A. García, I. Martín, R. Ibañez, JP. Cabello, J. Vaamonde (Ciudad Real, Spain)

    Objective: In patients with advanced Parkinson disease, it is possible to obtain a response to duodopa, if the dose is adjusted appropriately, even taking periods…
  • « Previous Page
  • 1
  • …
  • 128
  • 129
  • 130
  • 131
  • 132
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley